Sun Pharma Canada Inc., a wholly owned subsidiary of Sun Pharmaceutical Industries Limited ("Sun Pharma"), is pleased to announce the availability of ILUMYA (tildrakizumab) Pen, a self-administered ...
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS ...
This year's CES welcomes a new player. On January 6, Nebula Next made its debut at CES, officially unveiling the concept car ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback